imugene welcomes new chief medical officer and talks significant new patents
Published 2 years ago • 2K plays • Length 5:10Download video MP4
Download video MP3
Similar videos
-
1:11
chief medical officer, benjamin kornitzer, md, discusses agilon health's physician partnerships
-
4:45
leslie chong's first interview following our news imugene secured two fda ind approvals
-
6:43
imugene's leslie chong welcomes first patient dosed in checkvacc trial
-
6:29
imugene finishes phase 1a monotherapy dose escalation of pd1 vaxx
-
7:40
imugene limited (asx: imu) emergence 2024: presentation by leslie chong, managing director and ceo
-
5:20
imugene welcomes dosing of first patient in nextherizon phase 2 clinical trial
-
20:37
imugene (asx: imu) – the ‘holy grail’ of cancer treatment…?! | asx ceo interview 🚀📈
-
43:56
explaining identity acronyms: what is ispm and why does it matter?
-
20:57
imugene (asx: imu) - discussing imu's 2022 biotech opportunity
-
5:04
imugene (asx:imu) | jmm & éthica capital innovation interview \ may 2024
-
20:20
imugene science series with dr yuman fong - november 2024
-
4:30
imugene thrilled as vaxinia granted fda fast track designation
-
2:50
genewize interview with the chief medical officer
-
4:45
imugene receives ethics approval to start phase 2 clinical trial
-
1:06:25
imr-seameo webinar 2024
-
30:06
introducing taskforce, isms’ newest partner
-
5:30
imugene releases final data from phase 2 her-vaxx study
-
0:31
open enrollment 2023 – yupik